Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06951438 · ClinicalTrials.gov registry record · NA
Assessing Acceptability and Feasibiity of STI Self-swab Testing, to be Offered at the Time of Telemed Medication Abortion Provision
A NA study of Gonorrhea and Chlamydia, sponsored by Queen's Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT06951438: Recruiting NA study of Gonorrhea and Chlamydia, sponsored by Queen's Medical Center.
NCT06951438 is a NA study of Gonorrhea and Chlamydia that is actively recruiting participants, run by Queen's Medical Center. The registered enrollment target is 75 participants, below the 1,438-participant average among 10 other Gonorrhea trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06951438, a NA study of Gonorrhea and Chlamydia, is actively recruiting participants, sponsored by Queen's Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this interventional study is to provide more access to STI testing for patients who seek abortion care through telemedicine, particularly for those whose access to STI testing is otherwise limited. The main questions it aims to answer are: What is the acceptability, feasibility, and utilization of self-collected STI screening at the time of telemedicine medication abortion provision? How does the uptake of such a service among patients receiving telemedicine abortion care compare to the population of patients who seek in-person medication abortion care? What are the positivity rates for STIs in among patients receiving telemedicine medication abortion care compared to the positivity rates for a contemporaneous, in-clinic population? What is the average time to between testing and treatment for patients who test positive for an STI using the self-collection service? Researchers will compare the intervention group to a contemporaneous, in-clinic population on uptake of STI screening, as well as on positivity rates for the STIs tested. Participants will be asked to perform self-swab collection for STI testing for gonorrhea, chlamydia, and trichomonas. They will be instructed to send their specimens to a lab using prepaid postage. Upon completion of sample collection and shipping, they will be asked to complete a survey assessing basic demographic information, as well as acceptability and feasibility of the intervention. Patients who test positive for an STI will be promptly provided/referred to treatment.
Primary Outcome
Utilization rates will be reported as a percentage. Both enrollment in the study, as well as utilization of the actual STI testing services, will be reported as measures of utilization. The former (1) will be reported as the percentage of eligible patients who chose to enroll in the study, while the latter (2) will be reported as the percentage of enrolled patients who submitted samples for STI testing.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Self-swab collection PCR test for chlamydia, gonorrhea, trichomonas
Study Locations (1)
Hawaii
- Queens Medical Center, 1004 Clinic POB1 - Honolulu
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2025-05-22 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT06951438 shows while recruiting
NCT06951438 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,438-participant average among 10 other Gonorrhea trials with a reported enrollment target (95% lower).
The record links to 4 conditions, with Gonorrhea appearing as the primary indexed condition, and to 1 intervention - of which Self-swab collection PCR test for chlamydia, gonorrhea, trichomonas is the first listed.
NCT06951438 reports a single indexed study location in Hawaii.
Frequently Asked Questions
What is clinical trial NCT06951438 about?
NCT06951438 is a clinical study titled "Assessing Acceptability and Feasibiity of STI Self-swab Testing, to be Offered at the Time of Telemed Medication Abortion Provision". The goal of this interventional study is to provide more access to STI testing for patients who seek abortion care through telemedicine, particularly for those whose access to STI testing is otherwise limited. The main questions it aims to answer are: What is the acceptability, feasibility, and uti...
What is the current status of trial NCT06951438?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2025-05-22. Estimated completion is 2026-06-30.
What conditions does trial NCT06951438 study?
This clinical trial studies the following conditions: Gonorrhea, Chlamydia, Sexually Transmitted Disease (STD), Trichomonas Infection.
What interventions are being tested in trial NCT06951438?
The interventions under investigation include: Self-swab collection PCR test for chlamydia, gonorrhea, trichomonas (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06951438?
This trial is sponsored by Queen's Medical Center, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06951438 being conducted?
This trial has 1 study location across Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gonorrhea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06951438's enrollment target sits among peer trials
75 9th of 10 higher than 1 of 10 other Gonorrhea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gonorrhea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effectiveness of Relationship Education for Reducing HIV Incidence Among SGM
RECRUITING · NA
-
Zenyth: Motivational Interviewing-based Telehealth Intervention for Bacterial Sexually Transmitted Infection Screening
COMPLETED · NA
-
Multimedia WORTH With Black Drug-Involved Women on Probation
COMPLETED · NA
-
Online HIV Prevention for Young Male Couples
COMPLETED · Phase 2
-
A Dose-Ranging Study Evaluating the Efficacy, Safety, and Tolerability of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae
COMPLETED · Phase 2
-
Evaluation of the Atlas Genetics io® CTNG System
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI